$67.36 0.00 (%) Eli Lilly & Co - NYSE

Nov. 21, 2014 | 04:00 PM

Partner Headlines

  1. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD | Nov. 20, 2014 | 11:44AM EST
  2. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  3. Sarah Ketterer Dives in when Others Pull Out

    GuruFocus | Nov. 14, 2014 | 18:07PM EST
  4. Credit Suisse Raises Eli Lilly Price Target

    Benzinga | Nov. 3, 2014 | 12:05PM EST
  5. Veeva Systems Flies High On Cloud For Life Sciences

    IBD | Oct. 30, 2014 | 17:31PM EST
  6. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD | Oct. 29, 2014 | 12:51PM EST
  7. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD | Oct. 28, 2014 | 14:42PM EST
  8. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga | Oct. 23, 2014 | 07:41AM EST
  9. Earnings Scheduled For October 23, 2014

    Benzinga | Oct. 23, 2014 | 05:11AM EST
  10. CANDA NK-2 Files Motion To Dismiss Patent Infringement Suit

    Benzinga | Oct. 22, 2014 | 17:48PM EST
  11. Lilly, Zymeworks Announce Expansion Of Strategic Licensing And Collaboration Agreement

    Benzinga | Oct. 22, 2014 | 16:18PM EST
  12. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga | Oct. 19, 2014 | 10:19AM EST
  13. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD | Oct. 18, 2014 | 08:02AM EST
  14. UPDATE: Lilly To Initiate Efforts To Sell Guayama Site

    Benzinga | Oct. 16, 2014 | 14:33PM EST
  15. Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations

    Benzinga | Oct. 16, 2014 | 14:32PM EST
  16. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD | Oct. 14, 2014 | 13:10PM EST
  17. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts | Sep. 29, 2014 | 08:15AM EST
  18. Meet 5 Top International Stocks Not Based In China

    IBD | Sep. 22, 2014 | 19:43PM EST
  19. Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research Portfolio

    Benzinga | Sep. 22, 2014 | 07:17AM EST
  20. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga | Sep. 17, 2014 | 11:45AM EST
  21. Drug giants target Alzheimer's

    IBD | Sep. 16, 2014 | 18:49PM EST
  22. What Is A High Risk Market?

    Benzinga | Sep. 8, 2014 | 09:39AM EST
  23. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

    GuruFocus | Aug. 28, 2014 | 12:21PM EST
  24. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga | Aug. 27, 2014 | 17:17PM EST
  25. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga | Aug. 27, 2014 | 12:55PM EST
  26. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga | Aug. 27, 2014 | 12:32PM EST
  27. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now Available In U.S. Pharmacies

    Benzinga | Aug. 26, 2014 | 09:04AM EST
  28. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga | Aug. 1, 2014 | 15:48PM EST
  29. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga | Jul. 31, 2014 | 16:49PM EST
  30. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties

    Benzinga | Jul. 29, 2014 | 16:37PM EST
  31. Thursday Morning Earnings Reports

    Benzinga | Jul. 24, 2014 | 12:14PM EST
  32. Earnings Scheduled For July 24, 2014

    Benzinga | Jul. 24, 2014 | 05:31AM EST
  33. New Study Shows Beta-Amyloid Imaging Is Associated With Altered Diagnosis And Management Of Alzheimer's Disease

    Benzinga | Jul. 16, 2014 | 08:18AM EST
  34. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover And Co-Develop Novel Cancer Therapies

    Benzinga | Jul. 16, 2014 | 07:05AM EST
  35. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 15, 2014 | 08:14AM EST
  36. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga | Jul. 15, 2014 | 07:34AM EST
  37. Barclays Downgrades Pharmaceutical Sector

    Benzinga | Jul. 2, 2014 | 15:31PM EST
  38. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga | Jul. 2, 2014 | 09:40AM EST
  39. Benzinga's Top Upgrades

    Benzinga | Jul. 2, 2014 | 08:24AM EST
  40. Eli Lilly is on the Right Track

    GuruFocus | Jun. 25, 2014 | 11:02AM EST
  41. Celgene Sees Better Results For Psoriatic Arthritis

    IBD | Jun. 20, 2014 | 18:12PM EST
  42. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness | Jun. 20, 2014 | 12:31PM EST
  43. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD | Jun. 13, 2014 | 17:29PM EST
  44. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga | Jun. 4, 2014 | 13:58PM EST
  45. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy

    Benzinga | Jun. 4, 2014 | 10:32AM EST
  46. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus | Jun. 2, 2014 | 18:35PM EST
  47. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent Activity

    Benzinga | May. 14, 2014 | 17:05PM EST
  48. Eli Lilly insulin trial succeeds

    IBD | May. 12, 2014 | 18:42PM EST
  49. Cross-Border Megamergers Drive Global Takeover Boom

    IBD | May. 12, 2014 | 17:01PM EST
  50. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga | May. 12, 2014 | 16:27PM EST
Trading Center